Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Argho Ray

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 2020
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximabLaura S van Dam, Ebru Dirikgil, Edwin W Bredewold, et al.
The Clinical Teacher|January 20, 2026
Head-Mounted Cameras in Virtual Clinical LearningTessa A Mulder, Soufian Meziyerh, Argho Ray, et al.
BMJ Open|September 21, 2022
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trialEbru Dirikgil, Jolijn R van Leeuwen, Obbo W Bredewold, et al.
Kidney International Reports|March 8, 2022
Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody-Associated VasculitisJolijn R van Leeuwen, Obbo W Bredewold, Laura S van Dam, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2020
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year resultsTineke Kraaij, Eline J Arends, Laura S van Dam, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 2020
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximabLaura S van Dam, Ebru Dirikgil, Edwin W Bredewold, et al.
The Clinical Teacher|January 20, 2026
Head-Mounted Cameras in Virtual Clinical LearningTessa A Mulder, Soufian Meziyerh, Argho Ray, et al.
BMJ Open|September 21, 2022
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trialEbru Dirikgil, Jolijn R van Leeuwen, Obbo W Bredewold, et al.
Kidney International Reports|March 8, 2022
Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody-Associated VasculitisJolijn R van Leeuwen, Obbo W Bredewold, Laura S van Dam, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2020
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year resultsTineke Kraaij, Eline J Arends, Laura S van Dam, et al.
Pageof 1